Artal, Angel

Hospital Universitario Miguel Servet

1 paper on CoChatORCID 0000-0002-9778-706X

Most cited papers

Verified
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 5,489

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free